- Home
- KGS vs MLTX Comparison
KGS vs MLTX Comparison
Compare KGS & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KGS | MLTX |
|---|---|---|
| Founded | 2011 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 972.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | KGS | MLTX |
|---|---|---|
| Price | $36.74 | $13.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $43.00 | $36.33 |
| AVG Volume (30 Days) | ★ 1.8M | 1.7M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | ★ 5.34% | N/A |
| EPS Growth | ★ 224.29 | N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $1,284,748,000.00 | N/A |
| Revenue This Year | $14.03 | N/A |
| Revenue Next Year | $7.11 | N/A |
| P/E Ratio | $43.60 | ★ N/A |
| Revenue Growth | ★ 19.43 | N/A |
| 52 Week Low | $29.25 | $5.95 |
| 52 Week High | $50.43 | $62.75 |
Technical Indicators
Market Signals| Indicator | KGS | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.83 | 49.48 |
| Support Level | $35.19 | $13.32 |
| Resistance Level | $37.41 | $15.40 |
| Average True Range (ATR) | 0.91 | 0.77 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 49.72 | 31.64 |
Price Performance
Historical ComparisonAbout KGS Kodiak Gas Services Inc.
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.